Important Information about Albuterol Metered Dose Inhalers (MDIs)

May 30, 2008

After December 31, 2008, albuterol CFC MDIs are prohibited from being sold or distributed in the United States. Therefore, patients are encouraged to talk with their health care providers now to begin the transition to an HFA propelled albuterol MDI. After the transition is complete, it is anticipated that supplies of albuterol HFA and levalbuterol HFA MDIs will continue to meet the total market demand. FDA is working closely with manufacturers to ensure that there is adequate supply of the HFA propelled albuterol and levalbuterol MDI products available. (more information)

FDA Wants Quick Switch to Environmentally Friendly Albuterol Inhalers

May 30, 2008

ROCKVILLE, Md. -- Now is the time to switch asthma patients to hydrofluoroalkane (HFA)-propelled albuterol inhalers instead of the ones that use chlorofluorocarbon (CFC), the FDA advised today.

SAEM: AHA Guidelines for Cardiac Arrest Treatment Increase Survival

May 30, 2008

WASHINGTON -- The rate of resuscitation after out-of-hospital cardiac arrests jumped nearly four-fold when new guidelines on CPR were fully implemented in a North Carolina country, according to researchers here.

Nonalcoholic Fatty Liver Linked to Kidney Disease in Diabetic Patients

May 30, 2008

VERONA, Italy -- For patients with type 2 diabetes, non-alcoholic fatty livers may lead to chronic kidney disease, an observational study found.

New Mutations Linked to Sporadic Schizophrenia

May 30, 2008

NEW YORK -- About 10% of sporadic cases of schizophrenia appear to arise from spontaneous genetic mutations not inherited from either parent, researchers here said.

Prenatal Smoke Exposure Weakens Respiratory Control in Rat Pups

May 30, 2008

CALGARY, Alberta -- With an eye on a cause for sudden infant death syndrome, researchers here have found suggestive evidence in rats that maternal exposure to cigarette smoke during pregnancy may lead to impaired breathing in pups.

Viril-ity Power (VIP) Tablets

May 30, 2008

Product recalled because it contains a potentially harmful, undeclared ingredient that may interact with nitrates found in some prescription drugs and can lower blood pressure to life-threatening levels.

FDA Advises Patients to Switch to HFA-Propelled Albuterol Inhalers Now

May 30, 2008

CFC-propelled albuterol inhalers are being phased out because they are harmful to the environment by contributing to depletion of the ozone layer above the Earth's surface.

CMP Medica And NPA Issue Joint Statement On PIP Code, UK

May 30, 2008

The NPA and CMP Medica, the publishers of Chemist and Druggist, have issued a joint statement to clarify the licensing arrangements for the use and distribution of the PIP Code.The statement, which is published in full below, signals the intention of both organisations to continue to work together to safeguard the future of the PIP code and ensure it meets the needs of the pharmacy supply chain.

FDA proposes new pregnancy categories for prescription label

May 29, 2008

A new three-category label is in the works for pregnancy and breastfeeding information.

« Previous PageNext Page »